Evidence map›Paper›PMID 41026014›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2025

Americas Association of Sarcoidosis and other granulomatous disorders 2024 conference highlights.

Kristen Mathias, Anjali Wagle, Susana Dominguez-Peñuela, Carlos Pardo, Michelle Sharp, Nisha Gilotra

Abstract read
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kristen Mathias1Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Anjali WagleDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Susana Dominguez-PeñuelaDivision of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore.
Carlos PardoDivision of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore.
Michelle SharpDivision of Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore , Maryland.
Nisha GilotraDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Funding

Multidisciplinary Rheumatology Training ProgramT32AR048522 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLIFTON O BINGHAM, LIVIA A CASCIOLA-ROSEN · 2003 to 2026
$6.4M
Neurosarcoidosis: Clinical Phenotype, Biomarkers and ImmunopathogensisR01NS123712 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CARLOS A PARDO-VILLAMIZAR · 2022 to 2026
$3.3M
Medication Adherence and Clinical Outcomes in SarcoidosisK23HL148527 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHARP, MICHELLE · 2021 to 2025
$886k
Americas Association of Sarcoidosis and Other Granulomatous Disorders 2024: The Art of Working Together for ProgressR13HL176033 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GILOTRA, NISHA AGGARWAL, PARDO-VILLAMIZAR, CARLOS A · 2024 to 2024
$50k
NHLBI NIH HHS K23 HL148527NHLBI NIH HHS R13 HL176033NIAMS NIH HHS T32 AR048522NINDS NIH HHS R01 NS123712
6 · The paper itself

Abstract

The Americas Association of Sarcoidosis and Other Granulomatous Disorders (AASOG) 2024 conference, held in Baltimore, Maryland, leveraged a multidisciplinary approach to disseminating and addressing the latest updates, challenges and opportunities in multisystemic sarcoidosis. The conference, aptly titled "The Art of Working Together for Progress," featured insights from diverse perspectives in sarcoidosis both nationally and internationally. This review summarizes the key takeaways from the six conference sessions: I. Sarcoidosis Multidisciplinary Care, II. Health Disparities in Sarcoidosis, III. The Search for Precision in Sarcoidosis, IV. Clinical Outcomes in Sarcoidosis, V. Clinical Trials in Sarcoidosis, and VI. Advanced Disease in Sarcoidosis.

Identifiers

PMID41026014
PMCPMC12536846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.